41
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Drug utilization of ezetimibe in rehabilitation centres: registry analysis of factors influencing prescription and effectiveness of treatment

, , , , &
Pages 631-639 | Accepted 30 Jan 2006, Published online: 16 Feb 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

D. P. Mikhailidis, G. C. Sibbring, C. M. Ballantyne, G. M. Davies & A. L. Catapano. (2007) Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Current Medical Research and Opinion 23:8, pages 2009-2026.
Read now
Steven K. Hildemann, Christian Barho, Barbara Karmann, Harald Darius & Kurt Bestehorn. (2007) Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice. Current Medical Research and Opinion 23:4, pages 713-719.
Read now

Articles from other publishers (1)

Helle Wallach-Kildemoes & Ebba Holme Hansen. (2015) Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication. European Journal of Clinical Pharmacology 71:10, pages 1245-1254.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.